Programmed Cell Death 2-Like (PDCD2L) Peptide
PDCD2L
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN981493
Aperçu rapide pour Programmed Cell Death 2-Like (PDCD2L) Peptide (ABIN981493)
Antigène
PDCD2L
(Programmed Cell Death 2-Like (PDCD2L))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PDCD2L antibody (Catalog #: ARP50714_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
-
Sujet
-
Over expression of PDCD2L attenutates TNF-alpha release in Daudi cells. PDCD2L over-expression restrained proliferation of HEK293T cells. DNA/flow cytometry analysis showed that the over-expression of PDCD2L severely delays cell cycle progression at S phase. These all suggest that PDCD2L might play a role in apoptosis.
Alias Symbols: MGC13096
Protein Size: 358 -
Poids moléculaire
- 39 kDa
-
ID gène
- 84306
-
NCBI Accession
- NM_032346, NP_115722
-
UniProt
- Q9BRP1
Antigène
-
Vous êtes ici:
